Byhealth Past Earnings Performance
Past criteria checks 1/6
Byhealth has been growing earnings at an average annual rate of 19%, while the Personal Products industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 11% per year. Byhealth's return on equity is 6.3%, and it has net margins of 9.7%.
Key information
19.0%
Earnings growth rate
17.7%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | 11.0% |
| Return on equity | 6.3% |
| Net Margin | 9.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Byhealth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 7,358 | 714 | 4,082 | 172 |
| 30 Jun 24 | 8,424 | 1,092 | 4,388 | 168 |
| 31 Mar 24 | 8,945 | 1,443 | 4,434 | 182 |
| 31 Dec 23 | 9,407 | 1,746 | 4,351 | 179 |
| 30 Sep 23 | 9,484 | 1,805 | 4,236 | 178 |
| 30 Jun 23 | 9,237 | 1,883 | 4,034 | 174 |
| 31 Mar 23 | 8,689 | 1,752 | 3,736 | 155 |
| 31 Dec 22 | 7,861 | 1,386 | 3,562 | 158 |
| 30 Sep 22 | 7,563 | 1,573 | 3,359 | 157 |
| 30 Jun 22 | 7,454 | 1,431 | 3,292 | 165 |
| 31 Mar 22 | 7,489 | 1,601 | 3,095 | 166 |
| 31 Dec 21 | 7,431 | 1,754 | 2,868 | 150 |
| 30 Sep 21 | 7,091 | 1,720 | 2,896 | 163 |
| 30 Jun 21 | 7,168 | 1,934 | 2,680 | 142 |
| 31 Mar 21 | 6,822 | 1,806 | 2,444 | 138 |
| 31 Dec 20 | 6,095 | 1,524 | 2,250 | 140 |
| 30 Sep 20 | 5,914 | -80 | 1,852 | 119 |
| 30 Jun 20 | 5,417 | -261 | 1,865 | 122 |
| 31 Mar 20 | 5,186 | -319 | 1,976 | 123 |
| 31 Dec 19 | 5,262 | -356 | 2,078 | 126 |
| 30 Sep 19 | 5,310 | 1,132 | 2,204 | 124 |
| 30 Jun 19 | 5,151 | 1,161 | 2,023 | 122 |
| 31 Mar 19 | 4,854 | 1,125 | 1,875 | 102 |
| 31 Dec 18 | 4,351 | 999 | 1,681 | 103 |
| 30 Sep 18 | 4,182 | 1,018 | 1,537 | 93 |
| 30 Jun 18 | 3,794 | 885 | 1,380 | 110 |
| 31 Mar 18 | 3,442 | 852 | 1,246 | 100 |
| 31 Dec 17 | 3,111 | 763 | 1,208 | 77 |
| 30 Sep 17 | 2,747 | 771 | 924 | 45 |
| 30 Jun 17 | 2,562 | 759 | 891 | 0 |
| 31 Mar 17 | 2,389 | 594 | 857 | 0 |
| 31 Dec 16 | 2,309 | 535 | 883 | 0 |
| 30 Sep 16 | 2,398 | 619 | 910 | 0 |
| 30 Jun 16 | 2,322 | 577 | 915 | 0 |
| 31 Mar 16 | 2,344 | 655 | 856 | 0 |
| 31 Dec 15 | 2,266 | 635 | 825 | 0 |
| 30 Sep 15 | 2,101 | 609 | 732 | 0 |
| 30 Jun 15 | 1,944 | 566 | 659 | 0 |
| 31 Mar 15 | 1,806 | 530 | 612 | 0 |
| 31 Dec 14 | 1,705 | 503 | 567 | 0 |
| 30 Sep 14 | 1,704 | 547 | 505 | 0 |
| 30 Jun 14 | 1,668 | 542 | 480 | 0 |
| 31 Mar 14 | 1,594 | 481 | 474 | 0 |
| 31 Dec 13 | 1,482 | 422 | 466 | 0 |
Quality Earnings: 300146 has a large one-off gain of CN¥243.6M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300146's current net profit margins (9.7%) are lower than last year (19%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300146's earnings have grown by 19% per year over the past 5 years.
Accelerating Growth: 300146's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300146 had negative earnings growth (-60.5%) over the past year, making it difficult to compare to the Personal Products industry average (-6%).
Return on Equity
High ROE: 300146's Return on Equity (6.3%) is considered low.